与乳腺癌中大脑转移有关的分子机制和信号通路
Zhuming Liang1, Yanan Mo1, Yujiao Zhang1
1Department of Breast Surgery, The Affliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Frontiers in pharmacology
|April 11, 2025
概括
这篇评论探讨了乳腺癌 (BCBM) 中的大脑转移,重点关注分子机制和信号通路. 了解这些复杂性是开发新治疗方法的关键,用于三阴性和HER2阳性乳腺癌患者.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 乳腺癌 (BCBM) 中的大脑转移是死亡的主要原因.
- 三重阴性 (TNBC) 和HER2阳性乳腺癌特别容易发生大脑转移.
- 这个过程涉及复杂的分子机制和信号通路.
研究的目的:
- 审查最近关于BCBM分子机制和信号通路的研究.
- 突出BCBM的关键步骤,包括癌细胞透,血液传播和克服血脑屏障 (BBB).
- 确定潜在的治疗目标和策略,以改善患者的治疗结果.
主要方法:
- 关于BCBM最近研究的文献综述.
- 对参与BCBM进展的分子机制和信号通路的分析.
- 识别转移级联中的关键步骤.
主要成果:
- BCBM涉及癌细胞静脉注入,在循环中存活,在BBB中进行静脉注入和大脑殖民.
- 在BCBM中涉及的关键信号通路包括PI3K/AKT,STAT3,NF-κB,Notch和Wnt.
- 了解这些途径对于治疗干预至关重要.
结论:
- BCBM是一种由复杂的分子相互作用驱动的多方面的疾病.
- 对BCBM机制的进一步研究对于开发新型治疗策略至关重要.
- 针对特定的分子通路有望改善BCBM患者的生存率和生活质量.
相关概念视频
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


